Effect of intensive versus standard blood pressure control on cardiovascular outcomes in adult patients with hypertension: a systematic review and meta-analysis
- PMID: 39948181
- DOI: 10.1038/s41440-025-02131-0
Effect of intensive versus standard blood pressure control on cardiovascular outcomes in adult patients with hypertension: a systematic review and meta-analysis
Abstract
We conducted a systematic review and meta-analysis to evaluate the effects of intensive versus standard antihypertensive therapy on cardiovascular outcomes in adult patients with hypertension. The primary endpoints were composite cardiovascular events, all-cause death, cardiovascular death, and serious adverse events. The secondary endpoints included cognitive impairment, hypotension, syncope, acute kidney injury, and composite renal outcomes. Eight trials classifying a systolic blood pressure (SBP) target of <130 mmHg as intensive control was adopted in the primary analysis. The intensive blood pressure (BP) control significantly reduced the relative risk (RR) for cardiovascular events and cardiovascular death compared to standard BP control (RR 0.83 [95% confidence interval, 0.76-0.90] and 0.74 [0.56-0.97], respectively). The intensive BP control tended to reduce the RR for all-cause death, but not significant (0.89 [0.78-1.02]). On the other hand, the intensive BP control significantly increased the RR for serious adverse events, hypotension, and syncope (1.59 [1.19-2.12], 1.96 [1.04-3.70], and 2.36 [1.95-2.85], respectively). The intensive BP control significantly increased the RR for acute kidney injury (2.65 [1.78-3.95]), but did not affect for composite renal outcomes (1.38 [0.83-2.31]). For cognitive impairment, no significant increase or decrease in risk was observed (0.93 [0.68-1.26]). Based on these findings, we recommend the intensive BP control targeting SBP below 130 mmHg to achieve significant reductions in cardiovascular events and cardiovascular death, accompanied by careful monitoring for potential adverse events including acute kidney injury, hypotension, syncope related with the intensive BP control.
Keywords: Adverse events; Cardiovascular death; Cardiovascular events; Intensive blood pressure control; Standard blood pressure control.
© 2025. The Author(s), under exclusive licence to The Japanese Society of Hypertension.
Conflict of interest statement
Compliance with ethical standards. Conflict of interest: The authors declare no competing interests.
Similar articles
-
Optimal blood pressure target for patients with prior stroke: A systematic review and meta-analysis.Hypertens Res. 2025 Jun;48(6):1859-1869. doi: 10.1038/s41440-025-02183-2. Epub 2025 Mar 17. Hypertens Res. 2025. PMID: 40097615
-
Effects of blood pressure-lowering treatment on cardiovascular outcomes and mortality: 13 - benefits and adverse events in older and younger patients with hypertension: overview, meta-analyses and meta-regression analyses of randomized trials.J Hypertens. 2018 Aug;36(8):1622-1636. doi: 10.1097/HJH.0000000000001787. J Hypertens. 2018. PMID: 29847485 Review.
-
Benefit and harm of intensive blood pressure treatment: Derivation and validation of risk models using data from the SPRINT and ACCORD trials.PLoS Med. 2017 Oct 17;14(10):e1002410. doi: 10.1371/journal.pmed.1002410. eCollection 2017 Oct. PLoS Med. 2017. PMID: 29040268 Free PMC article. Clinical Trial.
-
Blood pressure targets for the treatment of people with hypertension and cardiovascular disease.Cochrane Database Syst Rev. 2020 Sep 9;9(9):CD010315. doi: 10.1002/14651858.CD010315.pub4. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2022 Nov 18;11:CD010315. doi: 10.1002/14651858.CD010315.pub5. PMID: 32905623 Free PMC article. Updated.
-
Systolic blood pressure targets below 120 mm Hg are associated with reduced mortality: A meta-analysis.J Intern Med. 2025 May;297(5):479-491. doi: 10.1111/joim.20078. Epub 2025 Mar 5. J Intern Med. 2025. PMID: 40041991 Free PMC article.
Cited by
-
JSH2025 guidelines new viewpoints.Hypertens Res. 2025 Jul 25. doi: 10.1038/s41440-025-02296-8. Online ahead of print. Hypertens Res. 2025. PMID: 40707654 No abstract available.
References
-
- Fujiyoshi A, Ohkubo T, Miura K, Murakami Y, Nagasawa S-y, Okamura T, et al. Blood pressure categories and long-term risk of cardiovascular disease according to age group in Japanese men and women. Hypertens Res. 2012;35:947–53. - PubMed
-
- Takashima N, Ohkubo T, Miura K, Okamura T, Murakami Y, Fujiyoshi A, et al. Long-term risk of BP values above normal for cardiovascular mortality: a 24-year observation of Japanese aged 30 to 92 years. J Hypertens. 2012;30:2299–306. - PubMed
-
- Flint AC, Conell C, Ren X, Banki NM, Chan SL, Rao VA, et al. Effect of systolic and diastolic blood pressure on cardiovascular outcomes. N Engl J Med. 2019;381:243–51. - PubMed
-
- Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387:957–67. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical